Your browser doesn't support javascript.
loading
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination.
Brown, Rachel A; Allegra, Luigi; Matera, Maria G; Page, Clive P; Cazzola, Mario.
Affiliation
  • Brown RA; Sackler Institute of Pulmonary Pharmacology, King's College London, Guy's Campus, London, UK.
Pulm Pharmacol Ther ; 19(6): 419-24, 2006.
Article in En | MEDLINE | ID: mdl-16807023
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Enoxaparin / Pulmonary Disease, Chronic Obstructive / Albuterol / Androstadienes / Anticoagulants Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Pulm Pharmacol Ther Journal subject: FARMACOLOGIA Year: 2006 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Enoxaparin / Pulmonary Disease, Chronic Obstructive / Albuterol / Androstadienes / Anticoagulants Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Pulm Pharmacol Ther Journal subject: FARMACOLOGIA Year: 2006 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido